| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.18 | 0.005 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.17 | 0.007 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |